Guided positional scanning method
US-2026018242-A1 · Jan 15, 2026 · US
This page is not indexed by search engines while we improve data quality.
Roemer Michael patents
Roemer Michael is listed as an inventor on 79 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Roemer Michael |
| Total patents | 79 |
| First publication | Jul 28, 2016 |
| Latest publication | Jan 15, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Peptides displayed by HLA for use in immunotherapy against different types of cancers
US-12318407-B2 · Jun 3, 2025 · US
Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods
US-2025145684-A1 · May 8, 2025 · US
Peptides displayed by HLA for use in immunotherapy against different types of cancers
US-12290530-B2 · May 6, 2025 · US
Peptides displayed by HLA for use immunotherapy against different types of cancers
US-12285443-B2 · Apr 29, 2025 · US
Peptides displayed by HLA for use immunotherapy against different types of cancers
US-12274716-B2 · Apr 15, 2025 · US
Peptides displayed by HLA for use in immunotherapy against different types of cancers
US-12257269-B2 · Mar 25, 2025 · US
Peptides displayed by HLA for use in immunotherapy against different types of cancers
US-12246039-B2 · Mar 11, 2025 · US
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
US-12227556-B2 · Feb 18, 2025 · US
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
US-12202878-B2 · Jan 21, 2025 · US
Recent patents
Latest publications not already listed above.
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
US-12195516-B2 · Jan 14, 2025 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024374642-A1 · Nov 14, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024374640-A1 · Nov 14, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024366669-A1 · Nov 7, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024358757-A1 · Oct 31, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024358756-A1 · Oct 31, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024358755-A1 · Oct 31, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024307447-A1 · Sep 19, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024299455-A1 · Sep 12, 2024 · US
Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
US-12084486-B2 · Sep 10, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024279306-A1 · Aug 22, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024269183-A1 · Aug 15, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024269184-A1 · Aug 15, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024254191-A1 · Aug 1, 2024 · US
Peptides displayed by hla for use in immunotherapy against different types of cancers
US-2024245723-A1 · Jul 25, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024247045-A1 · Jul 25, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024247044-A1 · Jul 25, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024239867-A1 · Jul 18, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024239865-A1 · Jul 18, 2024 · US
Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunotherapy against different types of cancers
US-2024239866-A1 · Jul 18, 2024 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Immatics Biotechnologies Gmbh | 75 |
| Grammer Ag | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K35/17 | 72 |
| C07K14/4748 | 72 |
| A61K40/11 | 65 |
| A61K40/42 | 64 |
| C07K14/70539 | 53 |